ArticleCureus2025
High Burden of Incidental and High-Grade Prostatic Carcinoma in Transurethral Resection of the Prostate (TURP) Specimens: A Retrospective Histopathological Analysis From Central India.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe histopathological evaluation of transurethral resection of the prostate (TURP) chips, primarily performed for benign prostatic hyperplasia (BPH), remains critical for the incidental detection of pre-malignant and malignant prostatic lesions in resource-limited settings lacking comprehensive screening. This study aimed to characterize the histopathological spectrum of prostatic pathology and the severity of incidentally detected cancer in a rural area of Central India.
methodsThis was a single-center, retrospective study analyzing 218 consecutive TURP chip specimens received between July 2024 and November 2025. Data, including histopathological diagnosis, age distribution, and International Society of Urological Pathology (ISUP) 2014 Grade Group (GG) for incidental carcinoma, were collected. The Pearson Chi-square test was used to assess the association between age and malignancy.
resultsOut of 218 specimens, 75.68% (n = 165) were benign, and 18.36% (n = 40) were malignant. The prevalence of incidental prostatic adenocarcinoma (IPCa) was high at 17.90% (39 cases). Crucially, 53.8% (n = 21) of these adenocarcinomas were classified as aggressive (Grade Group 3 or higher), indicating a substantial burden of intermediate-to-high-grade disease. A statistically significant association was found between age and the presence of malignancy (Chi-square = 12.06, df = 4, p = 0.017). The highest proportional malignancy rate (62.5%) was noted in the youngest age group (<50 years).
conclusionThe exceptionally high prevalence of incidental carcinoma and the significant proportion of high-grade disease (GG ≥ 3) underscore the necessity of mandatory and thorough histopathological evaluation of all TURP specimens, irrespective of pre-operative clinical findings, especially considering the high malignancy rate in younger men (<50 years), to ensure timely diagnosis and aggressive management in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.